What is Monopar Therapeutics's other current assets?

Monopar Therapeutics (MNPR) reported other current assets of $250.9K in Q1 2026.

How has Monopar Therapeutics's other current assets changed year-over-year?

Monopar Therapeutics's other current assets decreased by 52.1% year-over-year, from $523.56K to $250.9K.

What is the long-term trend for Monopar Therapeutics's other current assets?

Over 5 years (2020 to 2025), Monopar Therapeutics's other current assets has grown at a 0.3% compound annual growth rate (CAGR), from $62.69K to $63.75K.

Monopar Therapeutics MNPR Other current assets

Other current assets at other companies

Bristol-Myers SquibbBMY

$4.6B-16.9%

Eli LillyLLY

——

Prime MedicinePRME

——

Wave Life SciencesWVE

——

Lantheus HoldingsLNTH

——

Crinetics PharmaceuticalsCRNX

——

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's other current assets?: Monopar Therapeutics (MNPR) reported other current assets of $250.9K in Q1 2026.
How has Monopar Therapeutics's other current assets changed year-over-year?: Monopar Therapeutics's other current assets decreased by 52.1% year-over-year, from $523.56K to $250.9K.
What is the long-term trend for Monopar Therapeutics's other current assets?: Over 5 years (2020 to 2025), Monopar Therapeutics's other current assets has grown at a 0.3% compound annual growth rate (CAGR), from $62.69K to $63.75K.